SCHEMBL13493552

SCHEMBL13493552

Cc1cc2cc(-c3c(C)nc(NCC(F)(F)F)nc3N[C@H]3CC[C@@H](CO)C3)oc2c(OC(C)C)n1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12057987 0.89 PTPN11 (0.32) —
SCHEMBL12038734 0.85 IRAK4 (0.40) —
SCHEMBL12058157 0.83 PTPN11 (0.32) —
SCHEMBL12057712 0.83 IRAK4 (0.34) —
SCHEMBL13493510 0.81 IRAK4 (0.34) —
SCHEMBL12057865 0.81 IRAK4 (0.34) —
SCHEMBL12058173 0.78 IRAK4 (0.31) —
SCHEMBL12058431 0.78 CRHR1 (0.34) —
SCHEMBL12058302 0.77 CCNT1 (0.36) —
SCHEMBL12057848 0.77 IRAK4 (0.34) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010022121-A1 SUBSTITUTED PYRIDINE AND PYRIMIDINE DERIVATIVES AND THEIR USE IN TREATING VIRAL INFECTIONS SCHERING CORPORATION (US) 2010-02-25 — — WO disclosed
Send feedback